Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

External Collaboration At US FDA Is More Difficult Than At NIH, Sharpless Says

Executive Summary

Acting US FDA commissioner Norman Sharpless outlines some key differences between his new position and his former role at the NCI.

You may also be interested in...



“Nobody Was Armed At NCI”: US FDA Head Sharpless Adjusts To Life As Regulator

Acting commissioner is entering the usual learning curve for new leaders of the agency. It’s a reminder of how unusual it was to skip that step under his predecessor.

Independence, But Not Isolation: Panel Of FDA Commissioners Reflect On Role Of Dialogue With External Stakeholders

US FDA Commissioner Scott Gottlieb and three former agency heads tout value of deliberation with broader scientific community, but also agency's ability to make regulatory decisions independently.

Safety Events For Accelerated Approval Drugs Highlighted As Expansion Looms

US drugs with accelerated approval are more likely to experience a postmarket safety event, JAMA study finds; data sharing could be a solution to filling information gaps.

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel